ERBB2 and breast carcinoma: These results thus strongly suggest that p63 is essential for the pro-invasive SMAD-AP-1 program in these HER2+ and/or EGFR+ breast cancer cells, which may involve binding of p63 to SMAD and AP-1 binding regions [35].